Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development

[1]  M. Banks,et al.  Insights from Preclinical Choice Models on Treating Drug Addiction. , 2017, Trends in pharmacological sciences.

[2]  M. Banks,et al.  Effects of 21-day d-amphetamine and risperidone treatment on cocaine vs food choice and extended-access cocaine intake in male rhesus monkeys. , 2016, Drug and alcohol dependence.

[3]  W. Ling,et al.  Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study. , 2016, Addiction.

[4]  W. Stoops,et al.  Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research , 2016, Pharmacological Reviews.

[5]  M. Schwandt,et al.  The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects , 2016, Neuropsychopharmacology.

[6]  K. Rice,et al.  Effects of the kappa opioid receptor antagonist nor‐binaltorphimine (nor‐BNI) on cocaine versus food choice and extended‐access cocaine intake in rhesus monkeys , 2016, Addiction biology.

[7]  G. Koob,et al.  Existing and Future Drugs for the Treatment of the Dark Side of Addiction. , 2016, Annual review of pharmacology and toxicology.

[8]  L. Green,et al.  Delay discounting of food by rhesus monkeys: Cocaine and food choice in isomorphic and allomorphic situations. , 2015, Experimental and clinical psychopharmacology.

[9]  S. Negus,et al.  Use of Preclinical Drug Vs. Food Choice Procedures to Evaluate Candidate Medications for Cocaine Addiction , 2015, Current Treatment Options in Psychiatry.

[10]  T. Fennell,et al.  Effects of Phendimetrazine Treatment on Cocaine vs Food Choice and Extended-Access Cocaine Consumption in Rhesus Monkeys , 2013, Neuropsychopharmacology.

[11]  B. Blough,et al.  Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys. , 2013, Drug and alcohol dependence.

[12]  Serge H. Ahmed,et al.  Extended Heroin Access Increases Heroin Choices Over a Potent Nondrug Alternative , 2013, Neuropsychopharmacology.

[13]  M. Banks,et al.  Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-Administration , 2012, Advances in pharmacological sciences.

[14]  G. Koob,et al.  A Combination of Buprenorphine and Naltrexone Blocks Compulsive Cocaine Intake in Rodents Without Producing Dependence , 2012, Science Translational Medicine.

[15]  C. Gipson,et al.  Escalation of cocaine intake with extended access in rats: dysregulated addiction or regulated acquisition? , 2012, Psychopharmacology.

[16]  M. Banks,et al.  Making the Right Choice: Lessons From Drug Discrimination for Research on Drug Reinforcement And Drug Self‐Administration , 2011 .

[17]  M. Banks,et al.  Effects of Extended Cocaine Access and Cocaine Withdrawal on Choice Between Cocaine and Food in Rhesus Monkeys , 2010, Neuropsychopharmacology.

[18]  R. Brooner,et al.  The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. , 2009, Drug and alcohol dependence.

[19]  G. Bigelow,et al.  Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics. , 2009, Experimental and clinical psychopharmacology.

[20]  M. Banks,et al.  Escalation of food-maintained responding and sensitivity to the locomotor stimulant effects of cocaine in mice , 2009, Pharmacology Biochemistry and Behavior.

[21]  K. Rice,et al.  Mechanisms of Withdrawal-Associated Increases in Heroin Self-Administration: Pharmacologic Modulation of Heroin vs Food Choice in Heroin-Dependent Rhesus Monkeys , 2009, Neuropsychopharmacology.

[22]  S. Negus.  Opioid Antagonist Effects in Animal Models Related to Opioid Abuse: Drug Discrimination and Drug Self-Administration , 2009 .

[23]  R. Spealman,et al.  Controversies in translational research: drug self-administration , 2008, Psychopharmacology.

[24]  M. Le Moal,et al.  Addiction and the brain antireward system. , 2008, Annual review of psychology.

[25]  G. Koob,et al.  Stress, dysregulation of drug reward pathways, and the transition to drug dependence. , 2007, The American journal of psychiatry.

[26]  Serge H. Ahmed,et al.  Intense Sweetness Surpasses Cocaine Reward , 2007, PloS one.

[27]  R. Cardinal,et al.  Explaining the Escalation of Drug Use in Substance Dependence: Models and Appropriate Animal Laboratory Tests , 2007, Pharmacology.

[28]  M. Nader,et al.  Influence of abstinence and conditions of cocaine access on the reinforcing strength of cocaine in nonhuman primates. , 2006, Drug and alcohol dependence.

[29]  J. Mendelson,et al.  Effects of the CRF1 antagonist antalarmin on cocaine self-administration and discrimination in rhesus monkeys , 2006, Pharmacology Biochemistry and Behavior.

[30]  D. Rujescu,et al.  Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples , 2006, Molecular Psychiatry.

[31]  S. Negus.  Choice between Heroin and Food in Nondependent and Heroin-Dependent Rhesus Monkeys: Effects of Naloxone, Buprenorphine, and Methadone , 2006, Journal of Pharmacology and Experimental Therapeutics.

[32]  R. Depoortère,et al.  Tolerance to the reinforcing effects of cocaine in a progressive ratio paradigm , 1994, Psychopharmacology.

[33]  G. Koob,et al.  Desmethylimipramine attenuates cocaine withdrawal in rats , 2005, Psychopharmacology.

[34]  S. Negus.  Interactions between the reinforcing effects of cocaine and heroin in a drug-vs-food choice procedure in rhesus monkeys: a dose-addition analysis , 2005, Psychopharmacology.

[35]  D. Morgan,et al.  Effects of extended-access self-administration and deprivation on breakpoints maintained by cocaine in rats , 2005, Psychopharmacology.

[36]  S. Stevens Negus.  Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys , 2004 .

[37]  R. Griffiths,et al.  Principles of drug abuse liability assessment in laboratory animals. , 2003, Drug and alcohol dependence.

[38]  S. Negus.  Rapid Assessment of Choice between Cocaine and Food in Rhesus Monkeys: Effects of Environmental Manipulations and Treatment with d-Amphetamine and Flupenthixol , 2003, Neuropsychopharmacology.

[39]  S. L. Sell,et al.  Cocaine and amphetamine attenuate the discriminative stimulus effects of naltrexone in opioid-dependent rhesus monkeys. , 2002, The Journal of pharmacology and experimental therapeutics.

[40]  G. Koob,et al.  Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone , 1999, Psychopharmacology.

[41]  R. Foltin,et al.  A laboratory model of cocaine withdrawal in humans: intravenous cocaine. , 1997, Experimental and clinical psychopharmacology.

[42]  Y. K. Fung,et al.  Behavioural consequences of cocaine withdrawal in rats , 1994, The Journal of pharmacy and pharmacology.

[43]  M. Sullivan,et al.  Use of cocaine to prevent opiate withdrawal. , 1992, American Journal of Psychiatry.

[44]  B. Rounsaville,et al.  Coherence of the dependence syndrome in cocaine users. , 1991, British journal of addiction.

[45]  T. Kosten,et al.  COCAINE ABUSE AND OPIOID WITHDRAWAL , 1989, The Lancet.

[46]  H. Kleber,et al.  Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. , 1986, Archives of general psychiatry.

[47]  T. Yanagita.  Drug dependence studies in laboratory animals. , 1978, NIDA research monograph.

[48]  R. Griffiths,et al.  Discrete-trial choice procedure: effects of naloxone and methadone on choice between food and heroin. , 1975, Pharmacological reviews.

[49]  Saunders Kb.  END--OR BEGINNING? , 1965 .

[50]  S. Spragg.  Morphine addiction in chimpanzees. , 1940 .